Publications by authors named "J Reissigova"
Introduction: Upper limb (UL) impairment is common in people with multiple sclerosis (pwMS), and functional recovery of the UL is a key rehabilitation goal. Technology-based approaches, like virtual reality (VR), are increasingly promising. While most VR environments are task-oriented, our clinical approach integrates neuroproprioceptive 'facilitation and inhibition' (NFI) principles.
View Article and Find Full Text PDFIntroduction: Previous research has raised concerns about high prevalence of drug-related problems, polypharmacy and inappropriate benzodiazepine prescribing in nursing homes (NHs) and confirmed lack of studies from Central and South-Eastern Europe. The aim of our study was to determine the prevalence and characteristics of polypharmacy, hyperpolypharmacy and inappropriate benzodiazepine prescribing in NH residents in Croatia.
Methods: Data from 226 older NH residents from five Croatian NHs were collected using the InterRAI Long-Term Care Facilities assessment form.
Article Synopsis
- The study examines benzodiazepine (BZD) use among older adults (65+) in seven European countries, highlighting the prevalence and patterns of prescriptions.
- Among 2,865 study participants, 14.9% were BZD users, with Croatia, Spain, and Serbia showing the highest rates of use.
- Factors like female gender, anxiety, and depression were strongly linked to BZD use, revealing significant regional differences in prescribing practices across countries.
Article Synopsis
- The study compares the long-term effectiveness of originator-adalimumab and its biosimilar, SB5-adalimumab, in treating Crohn's disease patients who switched medications versus those who remained on the originator over a period of 104 weeks.
- At 52 weeks, clinical disease activity scores showed no significant difference between the two groups, with similar outcomes on related biological measures.
- However, treatment persistence was notably lower for the SB5-adalimumab group, with local skin reactions being a common reason for discontinuation.
Background: This study aimed to assess the declared benefits of the new test using antibodies against tissue transglutaminase in complex with gliadin representing a neo-epitope in the IgA and IgG class of immunoglobulins compared with currently used tissue transglutaminase antibodies in the IgA class of immunoglobulins among children.
Methods: In the cross-sectional study (P1 study, n = 406) and two small-size prospective observational studies (P2 study, n = 59 and P3 study, n = 12), serum samples from all children were simultaneously tested for endomysial antibodies, IgA tissue transglutaminase antibodies, and antibodies against tissue transglutaminase in complex with gliadin in the IgA and IgG class of immunoglobulins. The exact McNemar test, Wilcoxon test, and Spearman's correlation coefficient were used to analyze the data.